Status:
COMPLETED
Efficacy and Safety of the Neodymium Laser in Treatment of Urogenital Tract Diseases in Women
Lead Sponsor:
1st Federal Budgetary Healthcare Institution Volga District Medical Center
Conditions:
Genitourinary Syndrome of Menopause
Pelvic Floor Dysfunction
Eligibility:
FEMALE
29-72 years
Brief Summary
Study objective: To evaluate the efficacy and safety of the Magic Max neodymium laser in the medical treatment of women with symptoms of genitourinary syndrome of menopausal, vulvar lichen sclerosus a...
Detailed Description
Study objective: To evaluate the efficacy and safety of the Magic Max neodymium laser in the medical treatment of women with symptoms of genitourinary syndrome of menopausal, vulvar lichen sclerosus a...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- diseases of the urogenital tract
- symptoms of genitourinary menopausal syndrome,
- vulvar lichen sclerosus
- pelvic floor muscle reduction
- Exclusion criteria:
- pregnancy
- oncological diseases
Exclusion
Key Trial Info
Start Date :
January 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 24 2020
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT05251220
Start Date
January 1 2018
End Date
December 24 2020
Last Update
February 22 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Federal Budgetary Healthcare Institution "Volga District Medical Center" of the Federal Medical and Biological Agency
Nizhny Novgorod, Russia,Nighegorodskaya Oblast', Russia